Literature DB >> 30849786

Albumin-Indocyanine Green Evaluation (ALICE) grade combined with portal hypertension to predict post-hepatectomy liver failure.

Chikara Shirata1, Takashi Kokudo1, Junichi Arita1, Nobuhisa Akamatsu1, Junichi Kaneko1, Yoshihiro Sakamoto1, Norihiro Kokudo1,2, Kiyoshi Hasegawa1.   

Abstract

AIM: The aim of this study was to evaluate the role of liver function factors in predicting a postoperative large-volume ascites (LA) and post-hepatectomy liver failure (PHLF).
METHODS: We included 1025 consecutive patients undergoing hepatectomy for hepatocellular carcinoma between 2002 and 2014. Univariate and multivariate analyses were carried out to evaluate the role of each factor of liver function in predicting LA and PHLF. Factors included the presence of portal hypertension (PH), extent of resection, Model for End-stage Liver Disease (MELD) score, and Albumin-Indocyanine Green Evaluation (ALICE) grade.
RESULTS: The ALICE score was the strongest predictor for LA (odds ratio [OR], 5.02) and PHLF (OR, 10.94). Conversely, MELD score was not a significant predictive factor for LA or PHLF based on the multivariate analysis. In the ALICE grade 2 group, patients with PH showed a significantly high incidence of developing LA and experiencing PHLF compared with those without PH (LA, 22.4% vs. 10.3%, P < 0.001; PHLF, 8.6% vs. 1.3%, P < 0.001, respectively). Of patients in the ALICE 2 group, those undergoing sectoriectomy or more extensive resection were associated with extremely poor outcomes (LA, 54.2%; PHLF, 29.2%).
CONCLUSIONS: A combination of ALICE grade and presence of PH is a useful predictor of LA and PHLF.
© 2019 The Japan Society of Hepatology.

Entities:  

Keywords:  ascites; hepatectomy; hepatocellular carcinoma; liver failure; liver function; portal hypertension

Year:  2019        PMID: 30849786     DOI: 10.1111/hepr.13327

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

Review 1.  Update on perioperative management of patients undergoing surgery for liver cancer.

Authors:  Masaki Kaibori; Kosuke Matsui; Mitsuo Shimada; Shoji Kubo; Kiyoshi Hasegawa
Journal:  Ann Gastroenterol Surg       Date:  2021-12-15

2.  A cohort study of hepatectomy-related complications and prediction model for postoperative liver failure after major liver resection in 1,441 patients without obstructive jaundice.

Authors:  Bin Li; Yingyi Qin; Zhiquan Qiu; Jun Ji; Xiaoqing Jiang
Journal:  Ann Transl Med       Date:  2021-02

3.  Impact of aspartate aminotransferase-to-platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma.

Authors:  Kyohei Yugawa; Takashi Maeda; Shigeyuki Nagata; Jin Shiraishi; Akihiro Sakai; Shohei Yamaguchi; Kozo Konishi; Kenkichi Hashimoto
Journal:  World J Surg Oncol       Date:  2022-08-02       Impact factor: 3.253

Review 4.  Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma.

Authors:  Takashi Kokudo; Kiyoshi Hasegawa; Chikara Shirata; Meguri Tanimoto; Takeaki Ishizawa; Junichi Kaneko; Nobuhisa Akamatsu; Junichi Arita; Nicolas Demartines; Emilie Uldry; Norihiro Kokudo; Nermin Halkic
Journal:  Liver Cancer       Date:  2019-07-26       Impact factor: 11.740

5.  End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma.

Authors:  Fan-Hua Kong; Xiong-Ying Miao; Heng Zou; Li Xiong; Yu Wen; Bo Chen; Xi Liu; Jiang-Jiao Zhou
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

6.  Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report.

Authors:  Norifumi Harimoto; Kenichiro Araki; Ryo Muranushi; Kouki Hoshino; Kei Hagiwara; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Kei Shibuya; Masaya Miyazaki; Hirofumi Kawanaka; Ken Shirabe
Journal:  Surg Case Rep       Date:  2020-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.